MTOR and Hyperinsulinemia: Under conditions of hyperglycemia/hyperinsulinemia, PKCζ is activated and drives pancreatic β‐cell proliferation via the mammalian target of rapamycin (mTOR)–cyclin D2 axis, thus helping to preserve insulin secretory capacity [200, 201].